Subject Expert Committee Of The Central Drugs Standard Control Organisation

Rediff.com » News » Subject Expert Committee Of The Central Drugs Standard Control Organisation

News for Subject Expert Committee Of The Central Drugs Standard Control Organisation

News
Business

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

The move comes at a time when Omicron and its sub-variants have remained the dominant strains in circulation for close to two years now. Most of the vaccines available and administered in......

DCGI approves market authorisation for Covovax as Covid booster dose

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or......

Govt denies pressuring Covaxin makers for early release of vaccine

The Union health ministry on Thursday termed as 'misleading' and 'fallacious' media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.......

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

India's drug regulator has granted restricted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in......

Covishield, Covaxin get regular market approval

India's drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, official sources said.......

Quality Lapses Shut Down Drug Makers

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories. IMAGE: Kindly note the image has been posted only......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective......

It's a tough road ahead for pharma companies

Post Ranbaxy episode, domestic pharma companies may face frequent inspections and deeper scrutiny. These companies need to ensure that not only their own quality and standards improve but also......

Pranab Mukherjee's Budget Speech

Finance Minister Pranab Mukherjee presented the Budget for 2009-10 on July 6. Following is the BudgetSpeechof Finance Minister Pranab Mukherjee: Madam Speaker, I rise to present the Budget for......

Rediff News

Subject Expert Committee Of The Central Drugs Standard Control Organisation

News for Subject Expert Committee Of The Central Drugs Standard Control Organisation

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

DCGI approves market authorisation for Covovax as Covid booster dose

Govt denies pressuring Covaxin makers for early release of vaccine

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Covishield, Covaxin get regular market approval

Quality Lapses Shut Down Drug Makers

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

It's a tough road ahead for pharma companies

Pranab Mukherjee's Budget Speech

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS